UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported 08/08/2007)
Med Gen Inc.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 000-29171 65-0703559
- --------------------------- ---------------- -------------------
(State or other Jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
7284 West Palmetto Park Road, Suite #207, Boca Raton, FL 33433
- ---------------------------------------------------------------------------
(Address of principal executive offices)
561-750-1100
- ---------------------------------------------------------------------------
(Issuer's telephone number)
Not Applicable
- ---------------------------------------------------------------------------
(Former name or former address, if changed since last report)
All Correspondence to:
Paul B Kravitz CEO
C/O Med Gen Inc.
7284 West Palmetto Park Road
Suite #207
Boca Raton, FL 33433
Item 1.01 Entry into a Material Definitive Agreement
The lender has converted the following amount of shares to pay off
the second tranche of funding to the Company. Pursuant to an effective
Registration Statement on Form SB-2 the lender converted 171,111,111 common
shares from 8-16-2005 until 9-12-2006 into $1,205,000 and from 9-22-2006
until 8-8-2007 the lender converted 223,604,367 common shares into
$235,000.00. Thetotal debt paid off is $1,440,000.00 dollars.
At present the Company has borrowed eleven separate tranches from the
lenders.
These tranches are as follows:
March 30,2005 $740,000 Paid In Full
May 25,2005 $700,000 Paid In Full
August 23,2005 $100,000
August 31,2005 $500,000
October 26,2005 $600,000
February 23,2006 $600,000
April 21,2006 $750,000
August 10,2006 $1,500,000
January 10,2007 $350,000
February 14,2007 $350,000
June 21, 2007 $650,000
The Company has borrowed a total of $6,840,000 from its lenders and paid
back $1,440,000.00 dollars, leaving a balance due of $5,400,000 dollars.
The Company anticipates on closing a twelfth tranche in the sum of
$350,000.00 dollars in September 2007. Those proceeds will be used for
advertising and additional working capital.
The lenders can convert their loans into freely trading common shares on
the two year anniversary of their loan pursuant to Rule 144K. The
conversion formula is based upon a 50% discount to the lowest bid price as
reported by the OTCBB over the last 20 trading days.
Item 8.01 Other Events.
The Company has 965,230,117 million shares outstanding as of the date of
this filing and over 2750 total shareholders per ADP non-objecting
beneficial owners lists).The Company is authorized to issue up to
2,495,000,000 total common shares.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Med Gen Inc.
Date: August 8th, 2007
/s/Paul B. Kravitz
----------------------------------
Paul B. Kravitz,
Chairman & Chief Executive Officer